Sign inJoin free

Watch / Company News

Market Update | TechnologyOne, Mayne Pharma, Eagers Automotive, Catapult, Climb Global Solutions, Parenti Global

12:19 am today5:28

Market Update | TechnologyOne, Mayne Pharma, Eagers Automotive, Catapult, Climb Global Solutions, Parenti Global

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

The Australian sharemarket came under renewed pressure, with the ASX 200 falling around 1.5% in early trade, tracking a weaker session on Wall Street. Selling was broad-based, with few stocks managing to remain in positive territory. Investor sentiment was also weighed down by renewed inflation concerns after RBA Governor Michele Bullock reiterated that domestic demand and rising inflation expectations remain upside risks, beyond the impact of higher oil prices.

TechnologyOne delivered its 17th consecutive year of record profit, with FY26 net profit after tax increasing 19% to $163.4 million, at the top end of its upgraded guidance. Revenue rose 12% to $680.8 million, while expenses increased just 8%, supporting a two-percentage-point improvement in profit margins.

Annual recurring revenue climbed 18% to $652 million, despite a stronger Australian dollar reducing the result by approximately $8 million. The company declared a record final dividend of 32.5 cents per share, up 63%, taking its full-year dividend to 40.5 cents.

TechnologyOne remains focused on its longer-term targets of reaching $1 billion in annual recurring revenue by 2030, achieving profit margins of at least 35% and doubling in size every five years. It has not provided specific FY27 earnings guidance.

Mayne Pharma attracted a $604 million takeover bid from Hungarian pharmaceutical company Gedeon Richter, sending its shares sharply higher. The all-cash proposal values the company at $6.40 per share, approximately double its previous closing price.

The offer comes just a week after Mayne Pharma announced plans to sell its Adelaide manufacturing facility, adding another significant development for the company and its shareholders.

Eagers Automotive is expanding into the US market after agreeing to acquire a 65% stake in a new joint venture operating a multi-franchise dealership group in California.

The San Francisco Bay Area business generates approximately $450 million in annual turnover across four Toyota, Honda and Volkswagen dealerships, alongside four associated properties. The transaction is expected to be completed within 90 days and marks a significant step in Eagers' international expansion.

Sports technology company Catapult reached a major milestone, with annualised contract value exceeding $200 million for the first time.

For the first half, revenue increased 20% to US$81.7 million, while SaaS revenue rose 24%. Operating profit reached US$16.1 million, with margins expanding to 20%. Free cash flow increased to $9.3 million, and the company ended the period with $62 million in cash.

Catapult attributed its growth to professional sporting teams adopting multiple products across its platform. It is also looking to artificial intelligence to unlock further growth opportunities.

Climb Global Solutions was not the subject of a specific company update in the market commentary.

Parenti Global was briefly mentioned in the market update, with its shares trading around 0.2% higher. No further details of the company's announcement or operational performance were provided.

Overall, the market remains focused on the outlook for inflation and interest rates, with the RBA warning that strong domestic demand and rising inflation expectations could make it more difficult to bring price growth back towards its target. Consumer confidence recorded a modest rebound, rising 3.5 points to 66.6, although sentiment remains historically weak.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy